相关实验视频
Updated: Jul 29, 2025

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
3.6K
过敏原免疫疗法的机制和临床评估的潜在生物标志物
Umit M Sahiner1, Mattia Giovannini2,3, Maria M Escribese4
1Pediatric Allergy Unit, Department of Pediatrics, Hacettepe University School of Medicine, Hacettepe University Childrens Hospital, 06230 Ankara, Turkey.
Journal of personalized medicine
|May 27, 2023
概括
过敏原免疫疗法 (AIT) 通过诱导长期耐受性,有效治疗IgE介导疾病. 本综述探讨了AIT机制,并强调了对生物标志物的需求,以个性化治疗和改善结果.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 临床医学 临床医学
背景情况:
- 过敏原免疫疗法 (AIT) 是一种经过验证的治疗IgE介导的过敏性疾病,如过敏性鼻炎,昆虫毒素过敏,食物过敏和过敏性喘.
- AIT诱导临床免疫耐受性,即使在治疗停止后,也能提供持续的缓解.
- 关键机制包括抑制过敏炎症,促进阻断抗体 (IgG4,IgA) 和减少Th2细胞反应.
研究的目的:
- 审查目前对AIT机制的理解.
- 强调生物标志物对个性化AIT和改善患者护理的重要性.
- 探索如何更深入的机制学理解可以提高AIT的成果.
主要方法:
- 对过敏原-免疫疗法 (AIT) 机制的现有文献的审查.
- 专注于免疫路径,包括T细胞反应和细胞因子 (IL-10,TGF-β) 生产.
- 分析生物标志物在预测治疗反应和优化患者管理中的作用.
主要成果:
- AIT的功能是通过使效应细胞变得不敏感,并激活调节性T细胞.
- 机制包括细胞相互作用和免疫调节性细胞因子的释放.
- 生物标志物的识别对于将AIT定制为个别患者至关重要.
结论:
- AIT是一种IgE介导过敏的修饰疾病的治疗方法.
- 了解AIT的机制,特别是通过生物标志物,对于个性化医学至关重要.
- 对生物标志物的进一步研究将提高AIT的有效性和应用.
相关概念视频
Allergic Reactions
27.9K
Overview
27.9K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
361
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
361
Allergic Drug Reactions
901
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
901
Antibody Structure
60.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.5K
Cross-reactivity
31.4K
Overview
31.4K
Antigens Involved in Adaptive Immunity
568
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
568

